Company overview & History
BCI Pharma is an innovative biopharmaceutical company focused on small molecule drug discovery. We design and synthesize innovative kinase inhibitors libraries and combine with our HTS technology (Target and cell based assays). Thanks to our relevant platforms, we identify Novel, Potent and Selective Kinase Inhibitor Hits which are further optimized to preclinical candidates.
The company was founded by Dominique Surleraux and Elisabeth Picou in March 2013. Historically, BCI Pharma set up its medicinal chemistry lab in Montpellier (France) in April 2014. In September 2017, BCI’s biology lab was installed in Liège (Belgium). Since then, BCI’s headquarter is located in Belgium.